Value Plastics expands with eyes on Asia Pacific

Updated on 28 May 2012

Mr Philipp: Most of VP's competition in the APAC region comes from small operators with the capability to mold similar fittings for our customers. These local companies provide components at a very competitive price, however their quality and delivery is sometimes an issue. VP's products are manufactured in a cleanroom that conforms to very high quality controlled standards and dimensions. For a company manufacturing medical devices, the best way to reduce any risk associated with components is by using components from a high quality supplier such as VP. It is this difference in quality and regulatory compliance that sets us apart from what could be threatening competition, and gives us our loyal customer-base across APAC.

Can you elaborate on the future plans of the company?

Mr Philipp: On a general note, we intend to continue to expand VP's product lines of components to serve markets that we currently support and we will continue to seek and accommodate new markets that similarly have a need for high quality fittings. As for the type of our expected developments, all past and future plans revolve around a unique understanding of individual industries' needs - the recent expansion of VP's BioProcessing Line being a perfect example of this. With regards to APAC, we will continue to devise systems that allow customers to easily purchase VP products with minimal effort. Value Plastics has a strong and loyal customer base that feels confident relying on our great customer service, expansive selection, industry expertise, and commitment to product quality. Therefore, any plans for the future will be based around further improving these services and providing these solutions to more companies around the world.

1 3 Next

1Comment

Comment 1 - 1 of 1

Mark 8 June 2012 at 04 PM

Definitely Asia pacific is a growing market.

Reply

Leave a Reply

Post Comment

Special Features

Survey Box

Chinese Bird Flu H7N9

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X